Skip to content
Open access

Postpartum Blood Pressure After Hypertensive Disorders of Pregnancy and Subsequent Cardiovascular Disease: A Population-Based Cohort Study.

Oct 2026 · BJOG: an International Journal of Obstetrics and Gynaecology · 0 citations · 32 references
Medicine

Abstract

Objective

To assess the association between blood pressure values at 6 weeks postpartum and subsequent cardiovascular disease (CVD) over a 20-year period among women with hypertensive disorders of pregnancy (HDP).

Design

Population-based cohort study.

Setting

English primary and secondary care data, linked to cause-specific mortality records from 2000 to 2020. POPULATION A cohort of 39 934 women between 15 and 49 years of age at birth who had HDP, were registered with a general practitioner (GP) contributing to the Clinical Practice Research Datalink (CPRD), and eligible for linkage to hospital episode statistics (HES) data were included. We excluded 22 100 (55.3%) women with no blood pressure values recorded at 6 weeks postpartum.

Methods

Primary analysis included multivariable Cox regression modelling (weighted by the inverse probability of having a severe HDP). MAIN OUTCOME MEASURE Validated composite outcome of 12 cardiovascular diseases.

Results

The rate for incident cardiovascular events was 109 per 10 000 person-years; 794 (68%) of them occurred in women aged < 40 years. Women with abnormal blood pressure at 6 weeks postpartum had a higher risk of subsequent CVD than women with normal blood pressure: 10.9% vs. 5.4% - adjusted hazard ratio 1.96 (95% CI 1.51-2.54).

Conclusions

Less than half of women with HDP had a blood pressure record in their GP notes at 6 weeks postpartum. The absence of a record of normal blood pressure at this time point was associated with an increased risk for subsequent CVD The immediate postpartum period may be a crucial window in preventive care to improve women's health.

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.